Verdot key facts
as of Oct 2026- Manufacturer of purification equipment intended for the bio-pharmacy, cosmetology and food industries.
- Verdot is valued at approximately $68.7M as of Oct 2026 (last reported valuation).
- It has raised $10.4M; the latest was PE Growth/Expansion ($10.4M) in Jan 2025.
- Notable investors include SWEN Capital Partners, Caisse d'Epargne, Lauxera Capital Partners, BioProcess360, Capital Export — 8 tracked in total.
- Status: Privately Held (backing).
Verdot's last reported valuation, Jul 2022. Nothing priced has surfaced since.
- ·Watch Verdot: the Monday email on marks, rounds and moves
Verdot funding rounds
No funding rounds for Verdot are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Verdot valuation
Verdot's last reported valuation was $68.7 million in Jul 2022. No priced round, secondary trade or fund mark has surfaced since.
Verdot investors
8 investors are on record for Verdot, including SWEN Capital Partners, Caisse d'Epargne, Lauxera Capital Partners and BioProcess360.
About Verdot
Manufacturer of purification equipment intended for the bio-pharmacy, cosmetology and food industries. The company uses critical technology for the development and production of active ingredients for drugs, vaccines and biotechnological products for pharmaceutical clients.
- Sector
- Business Products and Services (B2B)
- HQ
- Riom, France
- Founded
- 1950
- Employees
- 63
- Website
- verdot-biotechnologies.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.